Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
BioCryst Pharmaceuticals, Inc. (BCRX) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BioCryst Pharmaceuticals, Inc. (BCRX) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for May 9th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 9th:
BioCryst Pharmaceuticals, Inc. (BCRX - Free Report) : This biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 285.7% over the last 60 days.
BioCryst Pharmaceuticals, Inc. Price and Consensus
BioCryst Pharmaceuticals, Inc. price-consensus-chart | BioCryst Pharmaceuticals, Inc. Quote
BioCryst’s shares gained 15% over the last three months compared with the S&P 500’s decline of 7.2%. The company possesses a Momentum Score of A.
BioCryst Pharmaceuticals, Inc. Price
BioCryst Pharmaceuticals, Inc. price | BioCryst Pharmaceuticals, Inc. Quote
WidePoint Corporation (WYY - Free Report) : This company that provides technology management as a service (TMaaS) has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 108.3% overthe last 60 days.
WidePoint Corporation Price and Consensus
WidePoint Corporation price-consensus-chart | WidePoint Corporation Quote
WidePoint’s shares gained 35.7% over the last three months compared with the S&P 500’s decline of 7.2%. The company possesses a Momentum Score of B.
WidePoint Corporation Price
WidePoint Corporation price | WidePoint Corporation Quote
Rambus Inc. (RMBS - Free Report) : This semiconductor products company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.9% overthe last 60 days.
Rambus, Inc. Price and Consensus
Rambus, Inc. price-consensus-chart | Rambus, Inc. Quote
Rambus’ shares gained 11.6% over the past month compared with the S&P 500’s advance of 6.9%. The company possesses a Momentum Score of B.
Rambus, Inc. Price
Rambus, Inc. price | Rambus, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.